217 related articles for article (PubMed ID: 37313814)
1. [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
Wang H; Sun Z; Zhao W; Geng B
Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):733-740. PubMed ID: 37313814
[TBL] [Abstract][Full Text] [Related]
2. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
3. S100 calcium-binding protein A10 contributes to malignant traits in osteosarcoma cells by regulating glycolytic metabolism via the AKT/mTOR pathway.
Ling F; Lu Q
Bioengineered; 2022 May; 13(5):12298-12308. PubMed ID: 35579448
[TBL] [Abstract][Full Text] [Related]
4. TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway.
Huang S; Zhao H; Lou X; Chen D; Shi C; Ren Z
Biochem Biophys Res Commun; 2024 Jul; 718():149983. PubMed ID: 38718735
[TBL] [Abstract][Full Text] [Related]
5. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway.
Chen X; Zhang W; Xu X
World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378
[TBL] [Abstract][Full Text] [Related]
6. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
Zhang H; Cao Y; Tang J; Wang R
Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
[TBL] [Abstract][Full Text] [Related]
7. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
8. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Ji Z; Pan X; Shang Y; Ni DT; Wu FL
Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
[TBL] [Abstract][Full Text] [Related]
9. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
Li J; Zhang W; Xia H; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
Xu Y; Chen X
Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
[TBL] [Abstract][Full Text] [Related]
12. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
13. S100A10 Accelerates Aerobic Glycolysis and Malignant Growth by Activating mTOR-Signaling Pathway in Gastric Cancer.
Li Y; Li XY; Li LX; Zhou RC; Sikong Y; Gu X; Jin BY; Li B; Li YQ; Zuo XL
Front Cell Dev Biol; 2020; 8():559486. PubMed ID: 33324631
[TBL] [Abstract][Full Text] [Related]
14. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway.
Liu C; Wang Y; Dao Y; Wang S; Hou F; Yang Z; Liu P; Lv J; Lv L; Li G; Zhou Y; Deng Z
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):99-112. PubMed ID: 35130633
[TBL] [Abstract][Full Text] [Related]
16. FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway.
Wang S; Liu B; Su Y; Wang N; Dong P; Xu X; Huang L; Li S; Gu J; Qiu Y; Deng J; Lin Z; Zhou Y
Thorac Cancer; 2024 Mar; 15(8):630-641. PubMed ID: 38323374
[TBL] [Abstract][Full Text] [Related]
17. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
18. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma.
Chen L; Kang Y; Jiang Y; You J; Huang C; Xu X; Chen F
Pathol Res Pract; 2022 Sep; 237():154031. PubMed ID: 35878532
[TBL] [Abstract][Full Text] [Related]
20. SLITRK6 promotes the progression of lung adenocarcinoma by regulating PI3K/AKT/mTOR signaling and Warburg effect.
Yu F; Zhao X; Li M; Meng M
Apoptosis; 2023 Aug; 28(7-8):1216-1225. PubMed ID: 37219677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]